Search

everythinglearnresearchcommunity

for

Search:↓

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

"Dread shed" is common with minoxidil but less so with other hair loss treatments.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Healthy women tend to lose more hair in July and April, and the least in February.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Hair shedding increases at the end of summer due to seasonal changes.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

CTE and FPHL are different hair loss types with unique causes.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Substances from dental stem cells might help treat hair loss.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Low-dose oral minoxidil improved hair growth in a woman with short anagen syndrome.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

The study concluded that hair growth in mice is regulated by a stable interaction between skin cell types, and disrupting this can cause hair loss.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Stingless bee propolis may help regenerate hair follicles and improve pigment function in chemotherapy-induced hair loss.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

The dietary supplement helped increase hair growth in women with hair loss.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.

Hyperbaric oxygen therapy may improve hair and scalp health.